Non-Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma

published 1 month ago by Dr Neil Love

Featuring a discussion on recent clinical trial data on the use of CAR T-cell therapy in the management of non-Hodgkin lymphoma with Dr Tanya Siddiqi, including the following topics: CAR T-Cell Therapy in B-Cell Non-Hodgkin Lymphoma — Tanya Siddiqi, MD (00:00) Case: A man in his late 50s with recurrent DLBCL attains complete remission after receiving axicabtagene ciloleucel on the Phase I/II ZUMA-1 trial (32:19) Case: A woman in her mid-60s with relapsed/refractory DLBCL receives lisocabtagene maraleucel on the Phase I TRANSCEND NHL 001 study (36:07) Case: A man in his late 60s with multiple regimen-relapsed CLL receives lisocabtagene maraleucel on the Phase I/II TRANSCEND CLL 004 study (38:34) Tumor lysis syndrome in patients receiving CAR T-cell therapy; FDA regenerative medicine advanced therapy designation for tisagenlecleucel in relapsed/refractory follicular lymphoma (43:08) CME information and select publications

more episodes from Research To Practice | Oncology Videos